|
Baseline |
Day 90 |
Day 180 |
|
T-treated (n = 12) |
|
|
|
| T (ng/dL) |
278 (40) |
647 (87)* |
528 (83)** |
| DHT (ng/dL) |
42 (5) |
156 (30)* |
160 (33)* |
| E2 (pg/mL) |
25 (2) |
35 (3)** |
41 (4)* |
|
Baseline
|
Day 30
|
Day 90
|
| DHT gel (n = 6) |
|
|
|
| T (ng/dL) |
358 (90) |
86 (14)* |
108 (45)** |
| DHT (ng/dL) |
67 (17) |
618 (233)* |
602 (213)* |
| E2 (pg/mL) |
25 (5) |
18 (2) |
20 (2) |
| Placebo gel (n = 3) |
|
|
|
| T (ng/dL) |
237 (6) |
295 (12) |
299 (21) |
| DHT (ng/dL) |
51 (1) |
55 (15) |
86 (20) |
| E2 (pg/mL) |
20 (1) |
22 (3) |
22 (5) |
|
| Combined T gel and T patch. Standard error of measurements (SEM) are
in parentheses. |
| *P < .01 compared with baseline; ** P < .05 compared
with baseline |
|
